Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Barriers to physical activity participation in colorectal cancer survivors at high risk of cardiovascular disease.

Maxwell-Smith C, Zeps N, Hagger MS, Platell C, Hardcastle SJ.

Psychooncology. 2016 Aug 1. doi: 10.1002/pon.4234. [Epub ahead of print]

PMID:
27478009
2.

Serious adverse event reporting in investigator-initiated clinical trials.

Wallace S, Myles PS, Zeps N, Zalcberg JR.

Med J Aust. 2016 Apr 4;204(6):231-3.

PMID:
27031396
3.

Theoretical versus Ex Vivo Assessment of Radiation Damage Repair: An Investigation in Normal Breast Tissue.

Ebert MA, Dhal B, Prunster J, McLaren S, Zeps N, House M, Reniers B, Verhaegen F, Corica T, Saunders C, Joseph DJ.

Radiat Res. 2016 Apr;185(4):393-401. doi: 10.1667/RR14235.1. Epub 2016 Mar 29.

PMID:
27023258
4.

A qualitative study exploring health perceptions and factors influencing participation in health behaviors in colorectal cancer survivors.

Hardcastle SJ, Maxwell-Smith C, Zeps N, Platell C, O'Connor M, Hagger MS.

Psychooncology. 2016 Mar 3. doi: 10.1002/pon.4111. [Epub ahead of print]

PMID:
26935994
5.

Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma.

Wang X, Goldstein D, Crowe PJ, Yang M, Garrett K, Zeps N, Yang JL.

Oncotarget. 2016 Apr 19;7(16):21496-509. doi: 10.18632/oncotarget.7452.

6.

Genomic analyses identify molecular subtypes of pancreatic cancer.

Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, Nourse C, Murtaugh LC, Harliwong I, Idrisoglu S, Manning S, Nourbakhsh E, Wani S, Fink L, Holmes O, Chin V, Anderson MJ, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Xu Q, Wilson PJ, Cloonan N, Kassahn KS, Taylor D, Quek K, Robertson A, Pantano L, Mincarelli L, Sanchez LN, Evers L, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Pajic M, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Lovell JA, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Moran-Jones K, Jamieson NB, Graham JS, Duthie F, Oien K, Hair J, Grützmann R, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Rusev B, Capelli P, Salvia R, Tortora G, Mukhopadhyay D, Petersen GM; Australian Pancreatic Cancer Genome Initiative, Munzy DM, Fisher WE, Karim SA, Eshleman JR, Hruban RH, Pilarsky C, Morton JP, Sansom OJ, Scarpa A, Musgrove EA, Bailey UM, Hofmann O, Sutherland RL, Wheeler DA, Gill AJ, Gibbs RA, Pearson JV, Waddell N, Biankin AV, Grimmond SM.

Nature. 2016 Mar 3;531(7592):47-52. doi: 10.1038/nature16965. Epub 2016 Feb 24.

PMID:
26909576
7.

A decision tool to guide the ethics review of a challenging breed of emerging genomic projects.

Joly Y, So D, Osien G, Crimi L, Bobrow M, Chalmers D, Wallace SE, Zeps N, Knoppers B.

Eur J Hum Genet. 2016 Aug;24(8):1099-103. doi: 10.1038/ejhg.2015.279. Epub 2016 Jan 20. Review.

PMID:
26785834
8.

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.

McCoy MJ, Hemmings C, Miller TJ, Austin SJ, Bulsara MK, Zeps N, Nowak AK, Lake RA, Platell CF.

Br J Cancer. 2015 Dec 22;113(12):1677-86. doi: 10.1038/bjc.2015.427. Epub 2015 Dec 8.

PMID:
26645238
9.

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?

McCoy MJ, Hemmings C, Hillery S, Penter C, Bulsara MK, Zeps N, Platell CF.

ANZ J Surg. 2015 Dec 3. doi: 10.1111/ans.13394. [Epub ahead of print]

PMID:
26631340
10.

An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.

Smit L, Berns K, Spence K, Ryder WD, Zeps N, Madiredjo M, Beijersbergen R, Bernards R, Clarke RB.

Oncotarget. 2016 Jan 19;7(3):2596-610. doi: 10.18632/oncotarget.6354.

11.

Consent to Donate Surgical Biospecimens for Research: Perceptions of People With Colorectal Cancer.

Williams AM, Allen J, Zeps N, Pienaar C, Bulsara C, Monterosso L.

Cancer Nurs. 2016 May-Jun;39(3):221-7. doi: 10.1097/NCC.0000000000000274.

PMID:
26050142
12.

Managing the Ethical Issues of Genomic Research using Pathology Specimens.

Zeps N, Bledsoe MJ.

Clin Biochem Rev. 2015 Feb;36(1):21-7.

13.

Whole genomes redefine the mutational landscape of pancreatic cancer.

Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD, Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES, Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Grützmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Gill AJ, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SM.

Nature. 2015 Feb 26;518(7540):495-501. doi: 10.1038/nature14169.

14.

A role for research ethics committees in exchanges of human biospecimens through material transfer agreements.

Chalmers D, Nicol D, Nicolás P, Zeps N.

J Bioeth Inq. 2014 Sep;11(3):301-6. doi: 10.1007/s11673-014-9552-1. Epub 2014 Jun 26.

PMID:
24965440
15.

Returning individual research results for genome sequences of pancreatic cancer.

Johns AL, Miller DK, Simpson SH, Gill AJ, Kassahn KS, Humphris JL, Samra JS, Tucker K, Andrews L, Chang DK, Waddell N, Pajic M, Pearson JV, Grimmond SM, Biankin AV, Zeps N.

Genome Med. 2014 May 29;6(5):42. doi: 10.1186/gm558. eCollection 2014.

16.

The International Cancer Genome Consortium's evolving data-protection policies.

Milius D, Dove ES, Chalmers D, Dyke SO, Kato K, Nicolás P, Ouellette BF, Ozenberger B, Rodriguez LL, Zeps N, Joly Y.

Nat Biotechnol. 2014 Jun;32(6):519-23. doi: 10.1038/nbt.2926. No abstract available.

PMID:
24911490
17.

A framework for biobank sustainability.

Watson PH, Nussbeck SY, Carter C, O'Donoghue S, Cheah S, Matzke LA, Barnes RO, Bartlett J, Carpenter J, Grizzle WE, Johnston RN, Mes-Masson AM, Murphy L, Sexton K, Shepherd L, Simeon-Dubach D, Zeps N, Schacter B.

Biopreserv Biobank. 2014 Feb;12(1):60-8. doi: 10.1089/bio.2013.0064.

18.

Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.

Collura A, Lagrange A, Svrcek M, Marisa L, Buhard O, Guilloux A, Wanherdrick K, Dorard C, Taieb A, Saget A, Loh M, Soong R, Zeps N, Platell C, Mews A, Iacopetta B, De Thonel A, Seigneuric R, Marcion G, Chapusot C, Lepage C, Bouvier AM, Gaub MP, Milano G, Selves J, Senet P, Delarue P, Arzouk H, Lacoste C, Coquelle A, Bengrine-Lefèvre L, Tournigand C, Lefèvre JH, Parc Y, Biard DS, Fléjou JF, Garrido C, Duval A.

Gastroenterology. 2014 Feb;146(2):401-11.e1.

PMID:
24512910
19.

CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.

Wang Y, Ren F, Wang Y, Feng Y, Wang D, Jia B, Qiu Y, Wang S, Yu J, Sung JJ, Xu J, Zeps N, Chang Z.

Carcinogenesis. 2014 May;35(5):983-91. doi: 10.1093/carcin/bgt393. Epub 2013 Dec 3.

20.

Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients.

Candy PA, Phillips MR, Redfern AD, Colley SM, Davidson JA, Stuart LM, Wood BA, Zeps N, Leedman PJ.

Br J Cancer. 2013 Aug 20;109(4):1023-30. doi: 10.1038/bjc.2013.431. Epub 2013 Jul 30.

Items per page

Supplemental Content

Write to the Help Desk